PROCEPT BioRobotics Corporation (PRCT) financial statements and ratios from SEC XBRL: revenue $308.05M (TTM), net margin -31.0%, revenue growth 37.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $308.05M |
| Net Margin | -31.0% |
| Revenue Growth (YoY) | 37.2% |
| EPS Growth (YoY) | -1.7% |
| FCF Growth (YoY) | -43.7% |
| Price / Book | 3.40 |
| Price / Sales | 3.75 |
| FCF Yield | -12.1% |
| Altman Z-Score | 4.01 (safe) |
| Piotroski F-Score | 3/9 |
| Sector P/E (Healthcare) | 21.6 |
PRCT overview · PRCT earnings · PRCT KPIs · PRCT investor relations · PRCT ownership · PRCT peers · PRCT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.